Option Care Health's (OPCH) "Outperform" Rating Reaffirmed at Barrington Research

Key Points

• Option Care Health's stock received an "outperform" rating from Barrington Research, with a target price of $38.00, indicating a potential upside of 37.28% from its current price.
• The company reported $1.42 billion in revenue for the last quarter, surpassing expectations, and also achieved an EPS of $0.41, beating estimates by $0.01.
• Insider purchases have increased, with significant shares purchased recently by directors, demonstrating increased confidence in the company's performance.

Option Care Health (NASDAQ:OPCH - Get Free Report)'s stock had its "outperform" rating restated by investment analysts at Barrington Research in a research note issued on Tuesday,Benzinga reports. They currently have a $38.00 target price on the stock. Barrington Research's price objective points to a potential upside of 37.28% from the company's current price.

A number of other equities research analysts also recently weighed in on OPCH. Citigroup restated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. JMP Securities raised their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Eight research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Option Care Health presently has an average rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Stock Performance

Option Care Health stock traded down $0.99 during trading on Tuesday, hitting $27.68. The stock had a trading volume of 1,016,936 shares, compared to its average volume of 1,852,664. The stock has a market cap of $4.49 billion, a price-to-earnings ratio of 22.12, a price-to-earnings-growth ratio of 1.72 and a beta of 0.83. The stock's 50 day moving average is $28.79 and its two-hundred day moving average is $31.17. Option Care Health has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter last year, the business posted $0.30 earnings per share. The firm's revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, analysts predict that Option Care Health will post 1.22 EPS for the current year.

Insider Buying and Selling

In related news, Director Norman L. Wright bought 3,411 shares of the firm's stock in a transaction on Tuesday, September 9th. The stock was acquired at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director owned 15,501 shares in the company, valued at approximately $454,334.31. This represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the firm's stock in a transaction on Wednesday, August 20th. The shares were bought at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the purchase, the director owned 375,390 shares in the company, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 59,411 shares of company stock worth $1,627,576 in the last three months. Insiders own 0.64% of the company's stock.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds have recently added to or reduced their stakes in OPCH. Durable Capital Partners LP raised its stake in Option Care Health by 134.2% during the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company's stock valued at $267,557,000 after buying an additional 4,720,988 shares during the last quarter. Norges Bank bought a new stake in shares of Option Care Health during the 2nd quarter valued at $69,932,000. Nuveen LLC bought a new stake in shares of Option Care Health during the 1st quarter valued at $70,965,000. Arrowstreet Capital Limited Partnership grew its position in shares of Option Care Health by 109.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company's stock valued at $110,770,000 after acquiring an additional 1,778,279 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its position in shares of Option Care Health by 6,525,926.1% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock valued at $52,459,000 after acquiring an additional 1,500,963 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.